Garheng Kong

Garheng Kong serves as a Board Director at Endpoint Clinical and leads as the Lead Director at LabCorp. As the Founder and Managing Partner of HealthQuest Capital since July 2012, Garheng Kong has focused on healthcare venture growth in medical products, devices, diagnostics, consumer health, and healthcare IT. Additional board roles include positions at Duke University Health System, Somatus, °Nomad Health, HistoSonics, Inc., Lunit, Ajax Health, and Everlywell. Garheng Kong holds an MD from Duke University School of Medicine, a PhD in Biomedical Engineering from Duke University, an MBA from The Fuqua School of Business at Duke University, and dual BS degrees in Chemical Engineering and Biological Sciences from Stanford University.